Where We Serve: Clear, Simple Availability Semaglutide weight loss programs are offered at our Bethlehem medical spa
[4] This earned Wegovy an additional FDA approval for cardiovascular risk reduction in March 2024
Weight-related comorbidities that qualify include type 2 diabetes, hypertension (high blood pressure), dyslipidemia (high cholesterol or triglycerides), obstructive sleep apnea, cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), and osteoarthritis of weight-bearing joints
Through its influence on the autonomic nervous system, the ARC modulates blood pressure, feeding behavior, glucose homeostasis, and innate immune responses [57]
In the diabetes trial, retatrutide decreased plasma triglyceride by up to 35% at 36 weeks compared with 4% reduction with dulaglutide and 9% with placebo [4]
Our specialists will work closely with you to monitor any side effects and make informed decisions about your treatment plan